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ABSTRACT In collaboration with the CDC’s Streptococcus Laboratory, we report here
the whole-genome sequences of seven Streptococcus agalactiae bacteria isolated
from laboratory-reared Long-Evans rats. Four of the S. agalactiae isolates were asso-
ciated with morbidity accompanied by endocarditis, metritis, and fatal septicemia,
providing an opportunity for comparative genomic analysis of this opportunistic
pathogen.
Streptococcus agalactiae, or group B streptococcus (GBS), is a Gram-positive oppor-tunistic pathogen that commonly inhabits the gastrointestinal and urogenital tract
of humans. It is the leading cause of neonatal septicemia and meningitis, and it is also
known to cause disease in animals, including meningoencephalitis in ﬁsh, mastitis in
cattle, and invasive infection in laboratory rodents (1–6). There is high suspicion that
GBS is a zoonotic pathogen, and despite close genotypic relationships observed
between different species’ isolates, direct transmission has not been reported (7–9). In
this report, we announce the whole-genome sequences of seven GBS isolates obtained
from a colony of laboratory-reared Long-Evans rats that experienced two cases of
polymicrobial sepsis associated with GBS infection in two gravid female rats; two
isolates were obtained from resected cardiac tissue and blood in the ﬁrst case, and two
isolates were obtained from cardiac tissue and fetus from the second case. An addi-
tional three asymptomatic male rats’ GBS isolates were cultured from the nares. Isolates
were 16S rRNA sequenced and submitted to the CDC’s Streptococcus Laboratory for
whole-genome sequencing.
The CDC’s Streptococcus Laboratory tracks cases of GBS invasive disease through
their Active Bacterial Core surveillance (ABCs). After receipt of isolates, genomic DNA for
short-read whole-genome sequencing was extracted manually using a modiﬁed
QIAamp DNA minikit protocol (Qiagen). Nucleic acid concentration was quantiﬁed by
an Invitrogen Qubit assay, and samples were sheared using a Covaris M220 ultrasoni-
cator programmed to generate 500-bp fragments. Libraries were constructed using
TruSeq DNA PCR-free high-throughput (HT) library preparation kit with 96 dual indexes
and quantiﬁed by a Kapa quantitative PCR (qPCR) library quantiﬁcation method.
Genomes were sequenced by Illumina NGS technology using MiSeq version 2 500-cycle
kit. Genomes were annotated using Rapid Annotations using Technology toolkit
(RASTtk) (10, 11) (http://rast.nmpdr.org/rast.cgi).
Strains underwent the following analyses: (i) multilocus sequence typing (MLST;
http://pubmlst.org/sagalactiae) (12), (ii) serotyping (13), (iii) detection of resistance
genes with ResFinder (14) and the Comprehensive Antibiotic Resistance Database
(CARD) (15), (iv) virulence factors (VFDB; http://www.mgc.ac.cn/VFs/) (16), and (v)
antimicrobial susceptibility testing by a microdilution broth method.
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MLST analysis and serotyping assigned all GBS strains except strain 195-16-B-RAT to
serotype Ib, sequence type 12 (ST12) (13, 17). Strain 195-16-B-RAT is serotype V, ST1.
Both serotype-sequence types are well-represented among human invasive isolates
documented in the 2015 ABCs (unpublished data). Isolates were susceptible to ampi-
cillin (0.25 g/ml), ceftriaxone (0.5 g/ml), erythromycin (0.25 g/ml), and clin-
damycin (0.25 g/ml) but resistant to tetracycline (8 g/ml). Strains were interme-
diate resistant to enroﬂoxacin (0.5 g/ml), a commonly used ﬂuoroquinolone in
veterinary medicine (18, 19). Strain 195-16-B-RAT had a mutation detected in the ermA
gene, denoting resistance to erythromycin. This may be due to inducible expression of
the resistance-causing methylase enzyme, which leads to different phenotypes (20). All
isolates had tet(M), associated with tetracycline resistance. The virulence factors iden-
tiﬁed were -hemolysin/cytolysin (cylE), CAMP factor (cfa/cfb), hyaluronate lyase (hylB),
C5a peptidase (scpB), pili (pilA, pilB, pilC), sortases (srtC3, srtC4), and Fg-binding surface
protein A and B (fbsA and fbsB).
Accession number(s). The whole-genome sequences of the seven S. agalactiae
strains have been deposited at DDBL/EMBL/GenBank under the accession numbers
provided in Table 1.
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